TLRY
Price
$0.97
Change
+$0.06 (+6.59%)
Updated
Nov 24, 04:59 PM (EDT)
Capitalization
1.08B
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

TLRY

Header iconTLRY Comparison
Open Charts TLRYBanner chart's image
Tilray Brands
Price$0.97
Change+$0.06 (+6.59%)
Volume$802.72K
Capitalization1.08B
TLRY Comparison Chart in %
TLRY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Avadel Pharmaceuticals plc (NASDAQ:AVDL), BioCryst Pharmaceuticals (NASDAQ:BCRX), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 4.11B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 3%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 15%. RGTLF experienced the highest price growth at 795%, while APUS experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was 16%. For the same stocks of the Industry, the average monthly volume growth was 48% and the average quarterly volume growth was 65%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 62
Price Growth Rating: 60
SMR Rating: 79
Profit Risk Rating: 90
Seasonality Score: -1 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Nov 25, 2025
Stock price -- (TLRY: $0.96)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TLRY’s FA Score shows that 0 FA rating(s) are green while.

  • TLRY’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TLRY’s TA Score shows that 4 TA indicator(s) are bullish.

  • TLRY’s TA Score: 4 bullish, 4 bearish.

Price Growth

TLRY (@Pharmaceuticals: Generic) experienced а -6.31% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.14%. For the same industry, the average monthly price growth was -6.34%, and the average quarterly price growth was +15.31%.

Reported Earning Dates

TLRY is expected to report earnings on Jan 12, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.14% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLRY
Capitalization1.08B
EBITDA-2.11B
Gain YTD-27.444
P/E RatioN/A
Revenue831M
Total Cash265M
Total Debt324M
FUNDAMENTALS RATINGS
TLRY: Fundamental Ratings
TLRY
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TLRY
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Momentum
ODDS (%)
N/A
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
TLRY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDNNX80.681.33
+1.68%
Janus Henderson Growth And Income N
LMSAX40.04N/A
N/A
ClearBridge Small Cap A
FNKIX18.25N/A
N/A
Frank Value Instl
MIAPX26.23N/A
N/A
Matthews Asia Growth Instl
IBARX25.68N/A
N/A
Macquarie Balanced Fund Class R6

TLRY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been closely correlated with SNDL. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if TLRY jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
+6.52%
SNDL - TLRY
76%
Closely correlated
+9.94%
CRON - TLRY
66%
Closely correlated
+3.16%
OGI - TLRY
64%
Loosely correlated
+5.74%
CGC - TLRY
63%
Loosely correlated
+3.15%
ACB - TLRY
61%
Loosely correlated
+4.04%
More